110 related articles for article (PubMed ID: 36786269)
1. Anti-Sars-CoV-2 vaccination campaign in children aged 5-11 years: the experience of a mass vaccination center in the city of Milan.
Astorri E; Mazziotta F; Macrelli C; Tiwana N; Letzgus M; Bisesti A; Laquintana D; Chiappa L; Piatti A; Sottocorno M; Falbo F; Rosso M; Caprini L; Castaldi S
Acta Biomed; 2023 Feb; 94(1):e2023036. PubMed ID: 36786269
[TBL] [Abstract][Full Text] [Related]
2. Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Oliani F; Savoia A; Gallo G; Tiwana N; Letzgus M; Gentiloni F; Piatti A; Chiappa L; Bisesti A; Laquintana D; Castaldi S
Vaccine; 2022 Mar; 40(10):1397-1403. PubMed ID: 35144846
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
5. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
[TBL] [Abstract][Full Text] [Related]
6. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
7. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
[TBL] [Abstract][Full Text] [Related]
9. Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study.
Li J; Ge M; Dai S; Song Q; Liu W; Wang Y; Xu W; Ma L
Front Immunol; 2022; 13():1030238. PubMed ID: 36420275
[TBL] [Abstract][Full Text] [Related]
10. Setting up and managing the largest COVID-19 mass vaccination center in Lombardy, Italy.
Calegari JG; Bisesti A; Pazzaglia S; Gambazza S; Binda F; Bruno M; Chiappa L; Piatti A; Tiwana N; Letzgus M; Castaldi S; Sottocorno M; Laquintana D
Front Public Health; 2023; 11():1290350. PubMed ID: 38045968
[TBL] [Abstract][Full Text] [Related]
11. Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.
Milani GP; Casazza G; Corsello A; Marchisio P; Rocchi A; Colombo G; Agostoni C; Costantino G
Ital J Pediatr; 2021 Jun; 47(1):145. PubMed ID: 34193222
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
[TBL] [Abstract][Full Text] [Related]
13. Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy.
Perrone PM; Scarioni S; Astorri E; Marrocu C; Tiwana N; Letzgus M; Borriello C; Castaldi S
Int J Environ Res Public Health; 2024 May; 21(6):. PubMed ID: 38928932
[TBL] [Abstract][Full Text] [Related]
14. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death.
Russo AG; Faccini M; Decarli A; Cattaneo S; Tunesi S; Murtas R; Fagandini F; Bergamaschi W
Epidemiol Prev; 2022; 46(5-6):324-332. PubMed ID: 36341584
[TBL] [Abstract][Full Text] [Related]
15. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost-Benefit Analysis.
Nurchis MC; Lontano A; Pascucci D; Sapienza M; Marziali E; Castrini F; Messina R; Regazzi L; Causio FA; Di Pilla A; Vetrugno G; Damiani G; Laurenti P
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805506
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-COVID-19 vaccination campaign in the Metropolitan Area of Milan (Lombardy Region, Northern Italy).
Russo AG; Tunesi S; Consolazio D; Decarli A; Bergamaschi W
Epidemiol Prev; 2021; 45(6):568-579. PubMed ID: 34791867
[TBL] [Abstract][Full Text] [Related]
18. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.
Canuti M; Monti MC; Bobbio C; Muscatello A; Muheberimana T; Baldi SL; Blasi F; Canetta C; Costantino G; Nobili A; Peyvandi F; Tettamanti M; Villa S; Aliberti S; Raviglione MC; Gori A; Bandera A;
Front Med (Lausanne); 2023; 10():1260950. PubMed ID: 37746083
[TBL] [Abstract][Full Text] [Related]
19. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
[TBL] [Abstract][Full Text] [Related]
20. Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Mancarella M; Natarelli F; Bertolini C; Zagari A; Enrica Bettinelli M; Castaldi S
Vaccine; 2022 Jun; 40(26):3664-3669. PubMed ID: 35570078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
